leronlimab

PRO140

DHHS recommendation not yet established
Entry Inhibitor

Standard Dose

One weekly subcutaneous (under the skin) injection of 350 mg used in clinical trials.

See package insert when available for more complete information on potential side effects and interactions.

Manufacturer

CytoDyn, Inc.
cytodyn.com

AWP

Not yet established.

Potential Side Effects and Toxicity

Potential Drug Interactions

More Information

Doctor Comments

Activist Comments